Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does lipitor's use influence blood pressure medication type?In what ways has the generic option influenced ruxolitinib's market share?Mebendazole 100mg price?How does insurance coverage impact nivolumab's duration?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab) dosing for psoriatic arthritis is commonly given as a set amount per subcutaneous injection, with a higher “loading” phase followed by maintenance. The usual regimen is: - Loading: 150 mg by subcutaneous injection once weekly for 5 weeks - Maintenance: 150 mg by subcutaneous injection every 4 weeks thereafter [1] Some patients may be prescribed 300 mg maintenance (two 150 mg injections) every 4 weeks, depending on prescriber assessment and response [1].
Cosentyx subcutaneous dosing is typically done using either: - 150 mg as a single injection, or - 300 mg as two 150 mg injections given back-to-back at the same time (same day) [1]
Dosing can vary based on the specific psoriatic arthritis presentation and clinical response, but the baseline approach is the same: weekly loading followed by every-4-weeks maintenance at either 150 mg or 300 mg [1].
If you miss a scheduled Cosentyx injection, the dosing schedule may need adjustment based on how long ago the missed dose was. For exact guidance, follow the prescribing information and your clinician’s instructions [1].
Other Questions About Cosentyx :